Derek Mann

Derek Mann

Newcastle University

H-index: 80

Europe-United Kingdom

About Derek Mann

Derek Mann, With an exceptional h-index of 80 and a recent h-index of 45 (since 2020), a distinguished researcher at Newcastle University, specializes in the field of fibrosis, epigenetics, gene regulation.

His recent articles reflect a diverse array of research interests and contributions to the field:

Apoptotic stress causes mtDNA release during senescence and drives the SASP (vol 622, pg 627, 2023)

Author Correction: Apoptotic stress causes mtDNA release during senescence and drives the SASP

A silver bullet for ageing medicine?: clinical relevance of T-cell checkpoint receptors in normal human ageing

Discovery of novel small molecule inhibitors of HDAC6 that suppress liver fibrosis

miRNA Expression in Fibroblastic Foci within Idiopathic Pulmonary Fibrosis Lungs Reveals Novel Disease-Relevant Pathways

Sublethal necroptosis signaling promotes inflammation and liver cancer

Impact of retrotransposon protein L1 ORF1p expression on oncogenic pathways in hepatocellular carcinoma: the role of cytoplasmic PIN1 upregulation

Immunotherapy resistance in NASH-HCC is driven by the dysfunctional liver microenvironment of NASH

Derek Mann Information

University

Position

Professor of Hepatology

Citations(all)

18345

Citations(since 2020)

7296

Cited By

14087

hIndex(all)

80

hIndex(since 2020)

45

i10Index(all)

180

i10Index(since 2020)

126

Email

University Profile Page

Newcastle University

Google Scholar

View Google Scholar Profile

Derek Mann Skills & Research Interests

fibrosis

epigenetics

gene regulation

Top articles of Derek Mann

Title

Journal

Author(s)

Publication Date

Apoptotic stress causes mtDNA release during senescence and drives the SASP (vol 622, pg 627, 2023)

Nature

Stella Victorelli

Hanna Salmonowicz

James Chapman

Helene Martini

Maria Grazia Vizioli

...

2023/10/19

Author Correction: Apoptotic stress causes mtDNA release during senescence and drives the SASP

Nature

Stella Victorelli

Hanna Salmonowicz

James Chapman

Helene Martini

Maria Grazia Vizioli

...

2024/1/2

A silver bullet for ageing medicine?: clinical relevance of T-cell checkpoint receptors in normal human ageing

Lucy Rimmer

Derek A Mann

Avan A Sayer

Shoba Amarnath

Antoneta Granic

2024/2/1

Discovery of novel small molecule inhibitors of HDAC6 that suppress liver fibrosis

Journal of Hepatology

Maria Teresa Borrello

Dušan Ružić

Fiona Oakley

Katarina Nikolić

Jelena Mann

...

2023

miRNA Expression in Fibroblastic Foci within Idiopathic Pulmonary Fibrosis Lungs Reveals Novel Disease-Relevant Pathways

The American Journal of Pathology

Laura Sabater

Jean B Gossart

Inmaculada Hernandez

Daniel Rico

Andy Blanchard

...

2023/4/1

Sublethal necroptosis signaling promotes inflammation and liver cancer

Immunity

Mihael Vucur

Ahmed Ghallab

Anne T Schneider

Arlind Adili

Mingbo Cheng

...

2023/7/11

Impact of retrotransposon protein L1 ORF1p expression on oncogenic pathways in hepatocellular carcinoma: the role of cytoplasmic PIN1 upregulation

British Journal of Cancer

Bassier Zadran

Praveen Dhondurao Sudhindar

Daniel Wainwright

Yvonne Bury

Saimir Luli

...

2023/3/30

Immunotherapy resistance in NASH-HCC is driven by the dysfunctional liver microenvironment of NASH

Journal of Hepatology

Daniel Geh

Erik Ramon Gil

Maja Laszczewska

Amy Collins

Saimir Luli

...

2023/6/1

Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach

Paul N Brennan

Ahmed M Elsharkawy

Timothy J Kendall

Rohit Loomba

Derek A Mann

...

2023/10

A phase I/II study of the CXCR2 inhibitor, AZD5069, in combination with durvalumab, in patients (pts) with advanced hepatocellular carcinoma (HCC).

TR Jeffry Evans

Bristi Basu

Richard Hubner

Yuk Ting Ma

Tim Meyer

...

2023/2/1

Modelling hepatocellular carcinoma in precision-cut liver slices for therapeutic screening and as a precision medicine tool

Journal of Hepatology

Amy Collins

Jack Leslie

Daniel Geh

Erik Ramon Gil

Maja Laszczewska

...

2023/6/1

c‐Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis

Hepatology

Jack Leslie

Jill E Hunter

Amy Collins

Amelia Rushton

Lauren G Russell

...

2023/10/1

UCHL1-dependent control of Hypoxia-Inducible Factor Transcriptional Activity in Liver Disease

bioRxiv

Amy Collins

Rebecca Scott

Caroline L Wilson

Giuseppe Abbate

Gabrielle Ecclestone

...

2023/1/8

Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch database

EClinicalMedicine

Weiqi Liao

Carol AC Coupland

Hamish Innes

Peter Jepsen

Philippa C Matthews

...

2023/5/1

The obese brain: is it a matter of time?

Ambica Bora

Alexandre Fisette

2023/8/26

Identification of a P62-TIF-IA axis that drives nucleolar fusion and the senescence associated secretory phenotype

bioRxiv

Hazel C Thoms

Tyler Brant

Katie Duckett

Yizheng Yang

Jinxi Dong

...

2023

Rencofilstat exerts a dominant role in synergistic anti-PD1-combination effects in a fatty liver model of hepatocellular carcinoma

Cancer Research

Daren Ure

Jack Leslie

Lacey Haddon

Claude Fu

Jelena Mann

...

2023/4/4

The exercise IL-6 enigma in cancer

Samuel T Orange

Jack Leslie

Mark Ross

Derek A Mann

Henning Wackerhage

2023/8/24

Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37

Maria Teresa Borrello

Derek Mann

2023/11

Human-correlated genetic HCC models identify combination therapy for precision medicine

Miryam Müller

Stephanie May

Holly Hall

Timothy J Kendall

Lynn McGarry

...

2022/5/12

See List of Professors in Derek Mann University(Newcastle University)

Co-Authors

H-index: 53
Michael May

Michael May

University of Pennsylvania

H-index: 53
Mark Harris

Mark Harris

University of Leeds

H-index: 28
Mo Ebrahimkhani

Mo Ebrahimkhani

University of Pittsburgh

H-index: 17
Aaron Ions Gardner

Aaron Ions Gardner

Newcastle University

academic-engine